Maravai LifeSciences reported revenue shifts and financial results for Q4 2024. They are focusing on growth strategies, acquisitions, and improving customer relationships. The company's financial outlook excludes COVID vaccine revenues.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay